Cancer Pain: Assessment and ManagementEduardo D. Bruera, Russell K. Portenoy Drs Eduardo D. Bruera and Russell K. Portenoy have completely revised and updated the widely respected Cancer Pain: Assessment and Management for the second edition of this unanimously praised book. This is a comprehensive, clinically oriented review of all aspects of the complex and multidimensional problem of cancer pain. The unique characteristics of cancer pain, including pathophysiology, clinical assessment, diagnosis, and pharmacological and nonpharmacological management are all discussed here in detail. Internationally recognized leaders in cancer pain research have contributed to many new chapters, including neuraxial analgesia, hospice and institution-based palliative care programs, bone pain, and cancer pain and palliative care in the developing world. Cancer Pain continues to be a scholarly but accessible text that is an essential resource for physicians, nurses, and medical students who treat suffering from cancer pain. |
Contents
SECTION IV PHARMACOLOGICAL | 165 |
EPIDEMIOLOGY treatment of cancer pain | 180 |
Juan Miguel JimenezAndrade Monica 12 Opioid side effects and management | 230 |
Antipyretic analgesics | 255 |
Adjuvant analgesic drugs | 272 |
Irene J Higginson and F liss Murtagh 15 NeuraXIaI analgesia | 287 |
measurement I6 Nfiural blockade for Cancer Pain | 315 |
Anderson LeonCasasola | 329 |
William S Breitbart Wendy G Lichtenthal | 457 |
27 | 478 |
Sebastiano Mercadante | 506 |
Badi El Osta and Eduardo D Bruera | 515 |
ethical and legal | 553 |
Understanding clinical trials in pain research | 568 |
pain management | 597 |
| 627 | |
Common terms and phrases
activity acute adjuvant administration advanced cancer allodynia analgesia analgesic antidepressants associated behaviors benefit bisphosphonates bone metastases bone pain breast cancer Bruera bupivacaine cancer pain cancer patients cell chemotherapy chronic pain Clin Oncol clinical clonidine cognitive defined delirium depression diagnosis difficult disease distress dose double-blind drug efficacy epidural evaluation factors fentanyl fibers findings first fractures gabapentin hospice hydromorphone hyperalgesia increased influence infusion inhibitors interventions intrathecal ketamine lesions long-term ment methadone mg/day morphine nerve neurons neuropathic pain nociceptive nonopioid NSAIDs Oncology opioid oxycodone pain assessment pain control pain intensity pain management pain relief Pain Symptom Manage pain syndromes Palliat palliative palliative care patients with advanced patients with cancer peripheral Pharmacol placebo postoperative potential prostate radiation radiotherapy randomized receptor reported response result risk scale sedation sensory side effects significant significantly specific spinal cord Ther therapy tion titration toxicity tramadol treat treatment trial tumor ziconotide